LRAT anticorps (N-Term)
Aperçu rapide pour LRAT anticorps (N-Term) (ABIN929344)
Antigène
Voir toutes LRAT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- LRAT antibody was raised in rabbit using the N terminal of LRAT as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
LRAT Blocking Peptide, (ABIN940320), is also available for use as a blocking control in assays to test for specificity of this LRAT antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LRAT (Lecithin Retinol Acyltransferase (Phosphatidylcholine--Retinol O-Acyltransferase) (LRAT))
-
Autre désignation
- LRAT
-
Sujet
- The protein encoded by this gene is a microsomal enzyme that catalyzes the esterification of all-trans-retinol into all-trans-retinyl ester, an essential reaction for the retinoid cycle in visual system and vitamin A status in liver. Mutations in this gene have been associated with early-onset severe retinal dystrophy. Synonyms: Polyclonal LRAT antibody, Anti-LRAT antibody, lecithin retinol acyltransferase, phosphatidylcholine--retinol O-acyltransferase antibody, MGC33103 antibody.
Antigène
-